Senior Vice President, Global Corporate Controller

Iovance Biotherapeutics(2 months ago)

RemoteFull TimeExecutive$375,000 - $420,000Finance

About this role

The Senior Vice President, Global Corporate Controller leads the company’s global accounting organization and oversees accounting policies, financial reporting, tax, treasury, and SEC/SOX compliance. This executive partners with senior leaders across the business and external auditors to ensure accurate and timely external reporting and strong governance. The role is focused on driving continuous improvement in accounting practices while building and developing a high-performing finance team.

View Original Listing

Required Skills

Accounting
Tax
Stock Administration
Payroll
SEC Reporting
Revenue Recognition
Financial Reporting
Financial Close
Treasury
Audit Management

+10 more

Qualifications

BA/BS in Accounting/Finance
CPA

About Iovance Biotherapeutics

iovance.com

Iovance Biotherapeutics is a clinical-stage biopharmaceutical company developing tumor-infiltrating lymphocyte (TIL) therapies that harness a patient’s own immune cells to recognize and kill diverse cancer cells. Its lead product, AMTAGVI (lifileucel), has received U.S. FDA accelerated approval for defined indications, and the company is advancing multiple clinical trials across solid tumors. Iovance builds and operates cell therapy manufacturing and Iovance Cell Therapy Centers to support production and commercialization, and partners with academic and industry collaborators to advance next‑generation T‑cell platforms. The company also provides patient resources, an expanded-access policy, and information about its pipeline and research.